Scott Morgan

17PUBLICATIONS

48CO-AUTHORS

Predictive and prognostic markersInstruments and techniquesCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsChemotherapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|May 26, 2026

Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis.

|May 19, 2026

From Guidance to Practice: Understanding the 2026 AUA/ASTRO Clinically Localized Prostate Cancer Guideline Amendment.

|Mar 11, 2026

From STORM to steadier ground: refining radiotherapy for nodal oligorecurrent prostate cancer.

Anindita Das, Scott C Morgan

|Jan 13, 2026

Association Between Sociodemographic Marginalization and Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer: Population-Based Cohort Study in Ontario, Canada.

David-Dan Nguyen, Raj Satkunasivam, Khatereh Aminoltejari

|Dec 24, 2025

Canadian Prostate Cancer Trends in the Context of PSA Screening Guideline Changes.

Anna N Wilkinson, Larry F Ellison, Shary X Zhang

|Dec 20, 2025

Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials.

Georges Gebrael, Neeraj Agarwal, Alicia K Morgans

Pageof 3

Frequent Collaborators

9 joint publications

Cristopher J D Wallis

Soumyajit Roy

Shawn Malone

Daniel E Spratt

Di Maria Jiang

Fred Saad

David-Dan Nguyen

Amar U Kishan

Michael Ong

Katherine F Y Chan

Frequent Collaborators

9 joint publications

Cristopher J D Wallis

8 joint publications

Soumyajit Roy

4 joint publications

Shawn Malone

3 joint publications

Daniel E Spratt